What can we learn from null randomized controlled trials?

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)691-693
Number of pages3
JournalJournal of the American Society of Nephrology
Volume24
Issue number5
DOIs
StatePublished - Apr 30 2013

Fingerprint

Polyamines
Chelating Agents
Chronic Renal Insufficiency
Randomized Controlled Trials

ASJC Scopus subject areas

  • Nephrology

Cite this

What can we learn from null randomized controlled trials? / Agarwal, Rajiv.

In: Journal of the American Society of Nephrology, Vol. 24, No. 5, 30.04.2013, p. 691-693.

Research output: Contribution to journalArticle

@article{b21d3f95fc1348f786e07eccacf15e11,
title = "What can we learn from null randomized controlled trials?",
author = "Rajiv Agarwal",
year = "2013",
month = "4",
day = "30",
doi = "10.1681/ASN.2013030295",
language = "English",
volume = "24",
pages = "691--693",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - What can we learn from null randomized controlled trials?

AU - Agarwal, Rajiv

PY - 2013/4/30

Y1 - 2013/4/30

UR - http://www.scopus.com/inward/record.url?scp=84877089056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877089056&partnerID=8YFLogxK

U2 - 10.1681/ASN.2013030295

DO - 10.1681/ASN.2013030295

M3 - Article

VL - 24

SP - 691

EP - 693

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -